Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Current Leases (2016)

Historic Current Leases for Viridian Therapeutics, Inc.\DE (VRDN) over the last 3 years, with Q4 2016 value amounting to $4000.0.

  • Viridian Therapeutics, Inc.\DE's Current Leases fell 9545.45% to $4000.0 in Q4 2016 from the same period last year, while for Dec 2016 it was $4000.0, marking a year-over-year decrease of 9545.45%. This contributed to the annual value of $4000.0 for FY2016, which is 9545.45% down from last year.
  • According to the latest figures from Q4 2016, Viridian Therapeutics, Inc.\DE's Current Leases is $4000.0, which was down 9545.45% from $88000.0 recorded in Q4 2015.
  • In the past 5 years, Viridian Therapeutics, Inc.\DE's Current Leases registered a high of $88000.0 during Q4 2015, and its lowest value of $4000.0 during Q4 2016.
  • Its 3-year average for Current Leases is $57333.3, with a median of $80000.0 in 2014.
  • In the last 5 years, Viridian Therapeutics, Inc.\DE's Current Leases soared by 1000.0% in 2015 and then tumbled by 9545.45% in 2016.
  • Over the past 3 years, Viridian Therapeutics, Inc.\DE's Current Leases (Quarter) stood at $80000.0 in 2014, then increased by 10.0% to $88000.0 in 2015, then tumbled by 95.45% to $4000.0 in 2016.
  • Its Current Leases stands at $4000.0 for Q4 2016, versus $88000.0 for Q4 2015 and $80000.0 for Q4 2014.